Therefore, this review presents the triangle relationship of obesity, DM as well as cancer development and elucidates the treatment of overweight-associated T2DM with semaglutide, focusing on the question of whether the development of these conditions can be combated or if any severe side effects should be considered of this therapy
Phentermine is indicated for short-term use (a few weeks) for patients with an initial BMI* of 30 or more (obese) or 27 or more (overweight) with at least one weight-related condition such as controlled high blood pressure, diabetes, or high cholesterol and should be used in combination with regular exercise and a reduced-calorie diet
Patients in the phase 3b clinical trial maintained about 75-80% of their weight loss and health benefits, such as reduced waist circumference and improvements in blood pressure, blood sugar, triglycerides and cholesterol levels
Stress on the body Any significant physiological change can trigger telogen effluvium, and dramatic weight loss is one of the most common triggers
& Russell-Jones, D
